A Potent Pharmacological Mushroom: Pleurotus eryngii
- *Corresponding Author:
- Zhiming Fu
Pharmaceutical Group Limited by Share Ltd
E-mail: [email protected]
Received date May 11, 2016; Accepted date June 21, 2016; Published date June 28, 2016
Citation: Fu Z, Liu Y, Zhang Q (2016) A Potent Pharmacological Mushroom: Pleurotus eryngii. Fungal Genom Biol 6:139. doi:10.4172/2165-8056.1000139
Copyright: © 2016 Fu Z, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Pleurotus eryngii, commonly known as the king oyster mushroom, has been used extensively in North Africa, Europe and Asia. A great deal of work has been carried out on therapeutic potential of Pleurotus eryngii. The edible Fungi perform multiple bioactivities: anticancer, antiviral, antioxidant, antimicrobial, anti-leukaemia, hypolipidemic, immuno-modulating and estrogen-like activity. These bioactive properties depend on its bioactive compounds such as polysaccharides, eryngiolide A, ubiquinone-9, pentacyclic triterpenoid and so on. The present review focuses on the potential pharmacological activities and provides reference for the study of Pleurotus eryngii in the future.